US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

      Summary Company Announcement Date: June 27, 2025 FDA Publish Date: June … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / Risperdal / Johnson & Johnson’s Action Spikes Risperdal Cases Filed in PA Court

Johnson & Johnson’s Action Spikes Risperdal Cases Filed in PA Court

June 21, 2017 By US Recall News Leave a Comment

Risperdal lawsuits are highly sensitive because the plaintiffs involved here are psychologically compromised young boys.

Risperdal (risperidone) is an antipsychotic medication that is believed to have caused mental and physical trauma and torture to young boys who grew breasts (gynecomastia), many of those who chose to a surgical remedy to remove excess breast tissue. Either way, gynecomastia can cause a long-lasting negative effect on social and mental functioning.

One favorable verdict for the plaintiffs can set the ball rolling for the other cases. However, it is also true that each case is unique. So far, defendant Janssen Pharmaceuticals, a subsidiary of multinational pharmaceutical conglomerate Johnson & Johnson, has lost in four of the eight cases that have gone to trial so far.

Risperdal (risperidone) manufactured by Janssen Pharmaceuticals, was approved by the Food and Drug Administration (FDA) in 1993 only for the treatment of schizophrenia in adults. Later, it was also approved for treatment of bipolar I disorder in children and adults, irritable dementia in the elderly, and autism spectrum disorders in children and adolescents. Gynecomastia, early onset puberty, tardive dyskinesia, type II Diabetes, cardiovascular disorders, death, floppy iris syndrome are some of the major side effects that are associated with this antipsychotic medication.

Research unveils facts that, as early as 2002, Johnson & Johnson marketed Risperdal to doctors who treated children prior to getting FDA approval of its use for that age group. This factor contributed to a stupendous rise in sales along with a parallel projection of Risperdal as a safer alternative as compared to the other market options. The Risperdal sales generated nearly $4.5 billion for the company during those times.

In 2006, scientific studies pointed out the link between Risperdal and gynecomastia including the fact that Risperdal complications were higher than the other market alternatives. Although J&J still denies these serious allegations, it is settling some Risperdal cases as it cannot deny the fact that approval for autistic disorder came only in 2006, and the approval for treatment of bipolar I disorder in children and adolescent schizophrenia came in 2007. This was also coupled with the 2008 report published in The Wall Street Journal that asserted Risperdal stimulated the production of prolactin in boys eventually leading to enlarged breast tissues.

The awareness brought about by related studies and patients resulted in the filing of the first lawsuit by six boys for gynecomastia in 2008, against J&J. The company settled a case in 2010 on the first day of trial. That case, which was filed by a 21-year-old-man, alleged physical and emotional trauma due to Risperdal. As more and more research studies were brought forth, in 2013 the Department of Justice began an investigation to determine whether or not the manufacturer had adequate labeling on the product. J&J finally pleaded guilty in November 2013 to the aggressive marketing of Risperdal for off-label uses and paying kickbacks to physicians and agreed to pay more than $2.2 billion in criminal and civil fines.

After the most recent verdict of $70 million in favor of the plaintiff, J&J canceled the tolling agreements. A tolling agreement imposes a pause on the statute of limitations to give potential claimants the chance to file legal action. This unilateral cancellation by J&J has resulted in thousands of cases being filed in addition to MDL Re: Risperdal Litigation, Case No: 100300296, at the Philadelphia Court of Common Pleas.

By now, it is a well-known fact that the J&J has paid in billions in Risperdal settlements and fines. On the other hand, it has released its first-quarter sales report of $17.8 billion as of April 2017, a 1.6% increase from its 2016 value which is a puzzling situation. Comparing the benefits of this drug with the distress it has caused to young and already suffering children is a debate, but to say that this litigation is far from over would be an understatement.

This article was submitted by Neural IT. Neural IT provides cost effective and timely medical reviews for screening potential mass tort cases. For more information, please visit www.neuralit.com. You may email us at info@neuralit.com or call +1-844-NIT-TEAM (648-8326).

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: Drug Recalls, Risperdal

About US Recall News

US Recall News provides recall news and information to the United States general public. Find all of the latest drug, food, products, and vehicle recall news as reported by U.S. government agencies and more.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

June 27, 2025 By The FDA

Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu

June 25, 2025 By The FDA

The Coleman Company Recalls Converta Camping Cots and Converta Camping Suspension Stretchers Due to Laceration and Amputation Hazards; Imported by Newell Brands

June 25, 2025 By The CPSC

Free Case Review

  • * = Required
    Privacy Policy
  • This field is for validation purposes and should be left unchanged.

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

DR Power Recalls Lithium-Ion Battery Packs Due to Fire and Burn Hazards

June 25, 2025 By The CPSC

Total Saddle Fit Recalls Western Saddle Cinches Due to Fall and Injury Hazards

June 25, 2025 By The CPSC

Professional’s Choice Sports Medicine Products Recalls Equine Bits Due to Fall Hazard

June 25, 2025 By The CPSC

LED Fireplace Lanterns Recalled Due to Risk of Serious Injury or Death from Ingestion Hazard; Violations of Federal Standard for Consumer Products with Coin Batteries; Imported by Green Pastures Wholesale

June 25, 2025 By The CPSC

Bell Sports Recalls Bicycle Helmets Due to Risk of Head Injury; Violation of Federal Standard for Bicycle Helmets

June 25, 2025 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

LED Fireplace Lanterns Recalled Due to Risk of Serious Injury or Death from Ingestion Hazard; Violations of Federal Standard for Consumer Products with Coin Batteries; Imported by Green Pastures Wholesale

June 25, 2025 By The CPSC

Bell Sports Recalls Bicycle Helmets Due to Risk of Head Injury; Violation of Federal Standard for Bicycle Helmets

June 25, 2025 By The CPSC

Sanven Technology Recalls Vevor Handrails Due to Injury Hazard

June 25, 2025 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
  • Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu
  • The Coleman Company Recalls Converta Camping Cots and Converta Camping Suspension Stretchers Due to Laceration and Amputation Hazards; Imported by Newell Brands
  • iHerb Recalls Bottles and Blister Packs of California Gold Nutrition Iron Supplements Due to Risk of Serious Injury or Death from Child Poisoning; Violation of Federal Standard for Child Resistant Packaging
  • Peg Perego Recalls Tatamia 3-in-1 Recliners, Swings and High Chairs Due to Risk of Suffocation; Violations of Multiple Federal Standards (Recall Alert)
  • DR Power Recalls Lithium-Ion Battery Packs Due to Fire and Burn Hazards
  • Total Saddle Fit Recalls Western Saddle Cinches Due to Fall and Injury Hazards
  • Professional’s Choice Sports Medicine Products Recalls Equine Bits Due to Fall Hazard
  • LED Fireplace Lanterns Recalled Due to Risk of Serious Injury or Death from Ingestion Hazard; Violations of Federal Standard for Consumer Products with Coin Batteries; Imported by Green Pastures Wholesale
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in